1. Home
  2. NAZ vs PLX Comparison

NAZ vs PLX Comparison

Compare NAZ & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Arizona Quality Municipal Income Fund

NAZ

Nuveen Arizona Quality Municipal Income Fund

HOLD

Current Price

$12.92

Market Cap

171.0M

Sector

Finance

ML Signal

HOLD

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

HOLD

Current Price

$2.20

Market Cap

168.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAZ
PLX
Founded
1992
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
171.0M
168.4M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
NAZ
PLX
Price
$12.92
$2.20
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$12.00
AVG Volume (30 Days)
16.7K
569.2K
Earning Date
01-01-0001
05-12-2026
Dividend Yield
3.69%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.22
Revenue
N/A
$52,744,000.00
Revenue This Year
N/A
$36.81
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$9.18
Revenue Growth
N/A
N/A
52 Week Low
$11.50
$1.34
52 Week High
$13.42
$3.19

Technical Indicators

Market Signals
Indicator
NAZ
PLX
Relative Strength Index (RSI) 51.87 62.05
Support Level $11.81 $2.03
Resistance Level $13.00 $2.42
Average True Range (ATR) 0.26 0.07
MACD -0.06 0.02
Stochastic Oscillator 48.45 98.93

Price Performance

Historical Comparison
NAZ
PLX

About NAZ Nuveen Arizona Quality Municipal Income Fund

Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Share on Social Networks: